1-1 of 1
Meng Ji
Close
Sort by
Journal Articles

Trial in Progress: A Phase 4 Multicenter Study of Brentuximab Vedotin Treatment in Chinese Patients with CD30-Positive Cutaneous T-Cell Lymphoma

Qian Wang, Ming Jiang, Chunlei Zhang, Sheng Wu, Wenhan Jiang, Meng Ji, Tong Chen
Journal: Blood
Blood (2022) 140 (Supplement 1): 12044–12045.
https://doi.org/10.1182/blood-2022-166617
Published: 2022